EU Acts On Drug Directive Breaches

30 July 1997

The European Commission is to take Belgium, France, Germany, Ireland andPortugal to the European Court for failing to adopt national legislation implementing EU directives.

Belgium and France have failed on Directive 92/73/EEC of December 1995, which aims to avoid discrimination and distortion of competition between homeopathic drugmakers and to give patients a free choice of medicines. Germany and Ireland have not adopted Directive 93/39/EEC, which abolishes barriers to the free movement of proprietary drugs and medicines, with member states' authorization decisions being based on quality, safety and efficacy alone. Portugal's infringement concerns veterinary products.

The Commission is also to direct reasoned opinions (the second stage in infringement procedures) to Austria, for only partly implementing Directive 89/381/EEC, which lays down special provisions for blood products derived from human blood or plasma, and 91/507/EEC, which sets out special product testing requirements.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight